Mackenzie Financial’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.45M | Buy |
165,917
+84,709
| +104% | +$738K | ﹤0.01% | 907 |
|
2025
Q1 | $646K | Buy |
81,208
+70,420
| +653% | +$561K | ﹤0.01% | 1115 |
|
2024
Q4 | $98.1K | Sell |
10,788
-92,165
| -90% | -$838K | ﹤0.01% | 1634 |
|
2024
Q3 | $945K | Sell |
102,953
-4,302
| -4% | -$39.5K | ﹤0.01% | 878 |
|
2024
Q2 | $1.05M | Buy |
107,255
+67,640
| +171% | +$662K | ﹤0.01% | 840 |
|
2024
Q1 | $598K | Buy |
39,615
+19,160
| +94% | +$289K | ﹤0.01% | 980 |
|
2023
Q4 | $441K | Sell |
20,455
-10,388
| -34% | -$224K | ﹤0.01% | 1032 |
|
2023
Q3 | $570K | Buy |
30,843
+14,050
| +84% | +$260K | ﹤0.01% | 967 |
|
2023
Q2 | $430K | Buy |
16,793
+2,193
| +15% | +$56.2K | ﹤0.01% | 1062 |
|
2023
Q1 | $378K | Buy |
+14,600
| New | +$378K | ﹤0.01% | 1102 |
|
2022
Q2 | – | Sell |
-29,296
| Closed | -$2.11M | – | 1542 |
|
2022
Q1 | $2.11M | Sell |
29,296
-3,141
| -10% | -$227K | ﹤0.01% | 745 |
|
2021
Q4 | $2.98M | Sell |
32,437
-9,193
| -22% | -$844K | ﹤0.01% | 680 |
|
2021
Q3 | $5.28M | Buy |
41,630
+4,030
| +11% | +$511K | 0.01% | 560 |
|
2021
Q2 | $6.25M | Buy |
37,600
+8,463
| +29% | +$1.41M | 0.01% | 519 |
|
2021
Q1 | $5.3M | Buy |
29,137
+1,058
| +4% | +$192K | 0.01% | 525 |
|
2020
Q4 | $5.62M | Buy |
28,079
+15,624
| +125% | +$3.12M | 0.01% | 428 |
|
2020
Q3 | $2.73M | Sell |
12,455
-2,042
| -14% | -$448K | 0.01% | 498 |
|
2020
Q2 | $2.77M | Buy |
+14,497
| New | +$2.77M | 0.01% | 488 |
|
2018
Q4 | – | Sell |
-33,800
| Closed | -$2.92M | – | 1231 |
|
2018
Q3 | $2.92M | Buy |
+33,800
| New | +$2.92M | 0.01% | 590 |
|